Clinical Trials Logo

Binge-Eating Disorder clinical trials

View clinical trials related to Binge-Eating Disorder.

Filter by:
  • Terminated  
  • Page 1 ·  Next »

NCT ID: NCT05911334 Terminated - Anorexia Nervosa Clinical Trials

Feasibility of the ROADE Program

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Occupational therapy is uniquely poised to help address chronic Eating Disorders (EDs) because of our holistic approach to client care. The complex and serious nature of EDs spans so many areas of life and wellbeing, it requires an intervention strategy that addresses the whole person across mental, physical, social, and spiritual realms. Unfortunately, specialized care for EDs can be difficult to find - especially for those not sick enough to be admitted to an inpatient facility but who are still struggling to thrive in daily life. For example, in New Mexico there is only one inpatient treatment center for EDs and no specialized outpatient services. This leaves many people suffering from EDs without options for care because they are not yet sick enough. There is a need for novel interventions in this setting that go beyond the traditional weight and food-focused medical interventions and seek to help empower individuals, work around challenges, and live their lives to the fullest. To meet this need in our community, the study team is developing a preliminary outpatient treatment program. The ROADE (Restorative Occupational Approaches for Disordered Eating) Program is an 8-week, structured, multimodal intervention seeking to reduce psychosocial symptoms and improve self-management skills for disordered eating. The intervention strategies range from: (1) wellness activities like mindfulness meditation to improve interoception, self-acceptance, and as a self-guided coping tool (2) adaptation of health management and self-care occupations to improve daily functioning while navigating ongoing disordered eating symptoms and (3) light exercise like Yoga and lymphatic drainage exercises to reconnect in a positive way with the body, improve digestion, promote relaxation, and reduce muscle tension. The current research investigates the feasibility and acceptability of this intervention while testing preliminary effects on eating disorder symptoms.

NCT ID: NCT04278755 Terminated - Eating Disorders Clinical Trials

Binge Eating & Birth Control

Start date: September 24, 2020
Phase: Phase 2
Study type: Interventional

This pilot study examines the effect of stabilizing ovarian hormones on eating behaviors and brain activation in women with binge eating (n=15) using functional magnetic resonance imaging (fMRI) and behavioral tests. This is completed by taking oral contraceptives (birth control) continuously for three months. Prior to medication administration and at the end of treatment, eating behaviors will be measured and fMRI will be conducted in order to examine changes in activation in dopamine-reward pathways that occur with oral contraceptive administration. This will assess changes in brain activation that occur with the stabilization of ovarian hormones.

NCT ID: NCT04181957 Terminated - Eating Behavior Clinical Trials

Effects of LDX on Cognitive Processes and Appetite

Start date: May 1, 2019
Phase: N/A
Study type: Interventional

This study will investigate the effect of lisdexamfetamine dimesylate (LDX) on the mediating factors of reward and cognition on appetite.

NCT ID: NCT03946111 Terminated - Obesity Clinical Trials

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders

Start date: August 7, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

This study will test the relative efficacy and effectiveness of the combination of naltrexone and bupropion (NB) medication as a treatment for binge-eating disorder (BED) in patients with obesity. This is a controlled test of whether, amongst non-responders to acute treatments, NB medication results in superior outcomes compared with placebo.

NCT ID: NCT03777189 Terminated - Clinical trials for Overweight and Obesity

Cognitive-Behavioral and Physical Activity Interventions for Binge Eating and Overweight

Start date: December 5, 2018
Phase: N/A
Study type: Interventional

This study aims to perform an open-series pilot trial to examine the efficacy of cognitive-behavioral therapy delivered in a guided self-help format (CBTgsh) with added content related to physical activity (PA), for the treatment of binge-eating disorder (BED), operationalized as BED full diagnostic criteria or BED with the full criteria except for the binge episode size criterion.

NCT ID: NCT03531112 Terminated - Weight Loss Clinical Trials

Reducing Binge Eating to Prevent Weight Gain in Black Women

Start date: January 12, 2019
Phase: N/A
Study type: Interventional

The purpose of the proposed study is to pilot a 6-month, cognitive-behavioral binge eating intervention, Appetite Awareness Training (AAT) to reduce binge eating and prevent weight gain for Black women with a BMI > 25 kg/m^2 and with weekly binge eating episodes. Intervention participants will receive a 8-week group AAT intervention, and will also receive bluetooth-connected scales for daily weighing. Participants will also receive tailored feedback on self-weighing frequency and weight change. The investigators will follow-up with participants at six months.

NCT ID: NCT03404713 Terminated - Clinical trials for Overweight and Obesity

Evaluating the Feasibility of a Stepped-care Approach to Treating Adolescents With Binge and Loss of Control Eating

Start date: February 15, 2018
Phase: N/A
Study type: Interventional

There are limited evidence-based treatments for adolescents with binge eating and fewer specifically targeting adolescents with both binge eating and overweight/obesity. The existing research for adolescents with overweight/obesity and loss of control (LOC) eating supports a stepped-care model of treatment in which enhanced behavioral weight loss treatment is the first line of treatment followed by more intensive therapeutic treatment for individuals with remaining emotional eating difficulties. Thus, in this proposed study, the investigators will systematically develop a stepped-care protocol and manualized interventions for adolescents with LOC and binge eating behaviors. The investigators will then evaluate the feasibility and acceptability of the interventions in a pilot trial and gather preliminary outcome data to inform development of a subsequent randomized controlled trial.

NCT ID: NCT03279731 Terminated - Clinical trials for Binge-Eating Disorder

Binge Eating Liraglutide Intervention

BELIEVE
Start date: September 29, 2017
Phase: Phase 3
Study type: Interventional

The study is a 17-week, single-center, double-blind, parallel-group, randomized placebo controlled trial that will test the efficacy of liraglutide 3.0 mg/d as compared to placebo in reducing the number of binge episodes per week, achieving remission from binge episodes, and in changes in body weight, global BED symptom improvement, cognitive restraint of food intake, dietary disinhibition, perceived hunger, quality of life, and depressed mood at treatment end.

NCT ID: NCT02817412 Terminated - Binge Eating Clinical Trials

Food Response Training for Binge Eating

Start date: June 2016
Phase: N/A
Study type: Interventional

This study will examine the effectiveness of food response training interventions in reducing binge eating among adults engaged in binge eating.

NCT ID: NCT02094027 Terminated - Obesity Clinical Trials

Bariatric Surgery and Guided Self-help for Binge Eating Disorder

BED
Start date: July 2011
Phase: N/A
Study type: Interventional

To demonstrate the effectiveness of an easily administered intervention (guided self help) aimed at reducing binge eating in patients undergoing bariatric surgery. The investigators hypothesize that patients who have guided self help pre-operatively will have reduced episodes of bingeing pre-operatively compared to those having treatment as usual (bariatric surgery), which will be maintained in the post-operative period, and will be associated with improved weight loss and psychological outcomes after surgery.